| Dr Jose Rapanan Jr, DO | |
|
10032 E Southern Ave, Mesa, AZ 85209-2759 | |
| (480) 351-2850 | |
| Not Available |
| Full Name | Dr Jose Rapanan Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 10032 E Southern Ave, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003341306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 008141 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Camelback Post Acute Care And Rehabilitation | Phoenix, AZ | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Post-acute Medical Services 1 Pc | 4688951239 | 18 |
| Banner Urgent Care Services Llc | 4284921610 | 198 |
| Sun Life Family Health Center Inc | 9335032275 | 47 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Sun Life Family Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891913166 PECOS PAC ID: 9335032275 Enrollment ID: O20040205000085 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | El Rio Santa Cruz Neighborhood Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487602736 PECOS PAC ID: 6305739244 Enrollment ID: O20040205000098 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Banner Urgent Care Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316349855 PECOS PAC ID: 3678749496 Enrollment ID: O20111228000784 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Southern Arizona Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285994004 PECOS PAC ID: 9335398031 Enrollment ID: O20121011000888 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Banner Urgent Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609229764 PECOS PAC ID: 4284921610 Enrollment ID: O20160928001188 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Arizona Post-acute Medical Services 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093254419 PECOS PAC ID: 4688951239 Enrollment ID: O20170508002340 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Entity Name | Nm Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366928749 PECOS PAC ID: 3375892060 Enrollment ID: O20200608000689 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose Rapanan Jr, DO Po Box 10097, Casa Grande, AZ 85130-0020 Ph: (520) 836-3446 | Dr Jose Rapanan Jr, DO 10032 E Southern Ave, Mesa, AZ 85209-2759 Ph: (480) 351-2850 |
News Archive
DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.
Elderly patients receive varying standards of dignified care on NHS hospital wards, new research jointly undertaken by the University of Kent has found.
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging.
A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 2 days ago
Jennifer Christine Fendler, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 924 N Country Club Dr, Mesa, AZ 85201 Phone: 480-601-3528 | |
George Ting, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1111 N Stapley Dr, Mesa, AZ 85203 Phone: 480-464-8500 | |
Dr. Thomas P Porter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1950 S Country Club Dr, Mesa, AZ 85210 Phone: 480-969-1446 Fax: 480-969-9105 | |
Dana S Farris, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10238 E Hampton Ave Ste 506, Mesa, AZ 85209 Phone: 480-834-7546 Fax: 480-833-8313 | |
Nancy Mucha, CNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2843 N 89th St, Mesa, AZ 85207 Phone: 480-396-3482 | |
Ryan Elisabeth Romo, Family Medicine Medicare: Medicare Enrolled Practice Location: 1705 W Main St, Mesa, AZ 85201 Phone: 877-809-5092 |